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Background: TGF- β1 is a pro¿ brotic cytokine that plays a major role in vas-
cular biology, and is known to regulate the phenotype and activity of various 
vascular cell populations. Because most ¿ brotic diseases, such as Idiopathic 
Pulmonary Fibrosis (IPF), are associated with vascular remodeling and since 
endothelial progenitor cells may be involved in this process, we investigated 
the impact of TGF- β1 modulation of endothelial progenitor cell angiogenic 
properties.
Patients/methods: TGF- β1 plasma levels were determined in 64 patients 
with IPF and compared to controls. The effect of TGF- β1 on angiogenesis was 
studied in vivo in a Matrigel plug model and in vitro on Endothelial Colony 
Forming Cells (ECFCs). We studied the effects of inhibiting the expression of 
the three main receptors of TGF- β1 in ECFCs using siRNA.
Results: Total TGF- β1 plasma levels were signi¿ cantly increased in 
patients with IPF compared to controls (p < 0.0001). TGF- β1 had proangio-
genic effects in vivo by increasing hemoglobin content and blood vessels 
formation in Matrigel- plugs implanted in C57/Bl6 mice and in vitro by enhan-
cing ECFC viability and migration. The effects were abolished by silencing 
the three main TGF- β1 receptors.
Conclusions: TGF- β1 is pro- angiogenic in vivo and induces ECFC angio-
genic properties in vitro, suggesting that TGF- β1 may play a role during vas-
cular remodeling in ¿ brotic disease states via endothelial progenitor cells.
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Impact of endovascular seeding of adipocyte- derived stem cells on ab-
dominal aortic aneurysm development
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Context: Abdominal aortic aneurysms (AAAs) are characterized by the loss 
of endothelial cells in the lumen and its replacement by an thick thrombus. 
Our hypothesis is that endothelium reestablishment through endothelial cell 
therapy would control AAA expansion. Recent studies have shown that the 
delivery of adipocyte- derived stem cells (ADSC) promotes endothelial repair 
in vivo, and that their preconditioning with an endothelial- speci¿ c culture 
medium potentiates their ability to improve endothelium function in vitro. The 
aim of this study was to study the impact of the local seeding of rat ADSC, 
cultured in mesenchymal (ADSC- M) or endothelial medium (ADSC- E) on 
AAA remodeling in rats.
Methods and results: ADSCs were isolated from male Fischer rats and 
cultured either in complete DMEM/F12 (ADSC- M) or ECGM- MV2 medium 
(ADSC- E). 3.106 ADSC- M (n=21), ADSC- E (n=20) or 200 L medium 
(control, n=15) were seeded endovascularly immediately after the xenograft 
in rats. In vivo, local ADSC- M transplantation did not prevent AAA deve-
lopment in rats (increased aortic diameters at D28: 106±15 vs 124±25% in 
ADSC- M and control groups, respectively, NS). In contrast, local ADSC- E 
delivery prevented AAA formation in rats (increased aortic diameter at D28: 
66±6 vs 124±25% in ADSC- E and control groups, respectively, p<0.01; 
66±6 vs 106±15% in ADSC- E and - M groups, respectively, p<0.05). This 
effect was accompanied by the restoration of endothelial lining and the for-
mation of a new extracellular matrix and smooth muscle cell- rich intimal 
wall. In vitro, endothelial preconditioning of ADSC decreased gene expres-
sion of pro- inÀ ammatory molecules (IL- 6, MCP- 1, LIF), increased those 
of anti- inÀ ammatory cytokines (IL- 10) and enhanced transcript level of 
endothelial- derived stabilizing factors (apelin, HIF- 2α, Tie- 2).
Conclusion: Only preconditioned ADSC using speci¿ c endothelial medium 
stabilize experimental AAAs, possibly through the release of endothelial- 
derived stabilizing factors.
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Vascular remodeling of the endocardium following cardiac infarction
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Coronary vasculature is required to maintain cardiomyocyte survival, via 
delivery of oxygen and nutrients, and consequently myocardial architecture and 
cardiac function. Ischemic heart disease following myocardial infarction causes 
irreversible cell loss and scaring and is a major cause of morbidity and mortality. 
Revascularization of injured, ischemic and regenerating organs is essential to 
restore organ function and requires the formation of new vessels by the mecha-
nisms of vasculogenesis, angiogenesis or arteriogenesis. With the objective of 
studying vascular remodeling during myocardial infarction (MI), we have per-
formed permanent left coronary ligation on Connexin40- GFP (Cx40GFP/+) mice. 
Cx40 encodes a gap junction protein and is expressed in endothelial cells of 
large vessels. In the heart, Cx40- GFP expression is detected in coronary arte-
ries but not in veins, capillaries or endocardium. After two weeks of ligation, 
MI was detected in left ventricle by echocardiography and anatomical exami-
nation of these hearts revealed the presence of an extensive network of GFP- 
positive vasculature within the infarct area. These vessels follow a tortuous 
route in the remaining ventricular wall and some communicate with the left 
ventricular lumen forming a crater covered with GFP and VEGF- R2 positive 
endothelial cells at the endocardial surface. To determine whether these vessels 
result from neo- vascularization or coronary artery remodeling, we carried out 
genetic lineage tracing of coronary endothelial cells using an inducible Cx40- cre 
allele. Our results show that GFP positive endothelial cells forming the endo-
cardial carters are not derived from pre- existing coronary arteries, suggesting 
that endocardial cells proximal to the opening of penetrating coronary arteries 
acquire a new phenotype post- infarction by expressing Cx40 and VEGF- R2. 
Recently, it has been shown that the endocardium is one of the cellular sources 
for coronary arteries during embryonic development. Our ¿ nding that endocar-
dial cells proximal to penetrating coronary arteries adopt an arterial phenotype 
after infarction suggests that endocardium may also contribute to the generation 
of new vessels during vascular remodeling in the adult heart.
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Therapeutic neovascularization represents an alternative treatment modality 
for patients with critical limb ischemia (CLI). 
Upregulation of HIF- 1α, through speci¿ c prolyl- hydroxylase domain protein 
(PHD) inhibition, can be thought of as a master switch that coordinates the 
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expression of a wide repertoire of genes involved in regulating vascular growth 
and remodeling. The aim of this study was to unravel the ef¿ ciency of speci¿ c 
PHD silencing in both cell and non cell- based therapeutic strategies in CLI. 
We used shRNAs to downregulate murine PHD levels and analyzed their 
ef¿ ciency as a therapeutic strategy in diabetic mice with hindlimb ischemia. 
PHD silencing increased post- ischemic neovascularization. This increase was 
associated with an up- regulation of VEGF- A and eNOS and with that of frac-
talkine, MCP- 1, and SDF- 1. In addition, concomitant silencing of PHD2 and 
HIF- 1α abrogated the shPHD2- related effects, demonstrating that activation of 
HIF- 1α signaling mediated the pro- angiogenic and pro- arteriogenic effects of 
shPHD2. Finally, we assessed the putative bene¿ cial effects of PHD silencing 
on progenitor cell- based therapies. Cells were transfected with siRNA directed 
against PHD and injected in Nude mice with hind- limb ischemia. We showed 
that PHD silencing enhanced human cells therapeutic effect in the ischemic 
leg of Nude mice compared to animals receiving untreated cells. 
In conclusion, our study reveals, for the ¿ rst time, that silencing of PHD 
by the transient and local upregulation of endogenous HIF- 1α improves the-
rapeutic angiogenesis. This study also paves the way for future strategy based 
on administration of siRNAs directed against PHD to enhance the ef¿ ciency 
of cell- based strategy.
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The fate of podosome- bearing aneurismal endothelial cells
Anne Leclercq [Orateur] (1), Owen Richards (2), Véronique Veillat (1), 
Sandrine Loriot (3), Franscesco Madonna (4), Xavier Roques (4), Jean 
Rosenbaum (3), David Klenerman (2), Elisabeth Génot (1)
(1) INSERM U1053 - IECB, Pessac, France - (2) chemistry department, 
Cambridge, Royaume- Uni - (3) INSERM U1053, Bordeaux, France - 
(4) hôpital Haut- Lévèque, Pessac, France
Primary endothelial cells (ECs) are endowed with podosome formation capa-
cities. In vitro, Bovine Aortic ECs stimulated with exogenous TGFb assemble 
podosome- rosettes which degrade the underlying matrix. Our aim is to decipher 
whether or not these ¿ nding have relevance in human vascular pathophysiology.
TGFb and related signaling molecules are known to play a role in Thoracic 
Aortic Aneurisms. By immunohistochemistry we found TGFb both at the level 
of the intimal endothelium and the adventitial vasa vasorum of human aneurismal 
tissue samples. To look for podosomes in these ECs endogenously and chroni-
cally exposed to TGFb, we set up a method to isolate intimal and adventitial 
ECs from the aorta. Podosome- forming cells were found in 90% of EC cultures 
derived from patient samples. This phenotype was maintained upon passaging. 
Matrix degradation capacities were con¿ rmed using the gelatin degradation assay. 
An optimization of phase- contrast imaging techniques allowed us to directly 
visualize these structures and assess their life span in living cells, overcoming 
putative artifacts associated with the use of transfection agents or actin overex-
pression systems. These podosomes appeared like transcellular columns of ¿ la-
mentous actin as observed by confocal imaging after phalloidin staining and this 
was con¿ rmed by Scanning Ion Conductance Microscopy (SICM). The nanoscale 
topologic description of the dorsal cell surface showed a rosette- print mirroring 
the actin- rich podosome phase- contrast and À uorescent images. Podosome rosettes 
mediate cell adhesion at the ventral membrane but owing to the extreme thinness 
of these cells, the rosette also protrudes on the dorsal side. Moreover, these podo-
somes also formed in conÀ uent cells indicating that the condition mimicking the 
native endothelium are permissive for podosome formation.
This physiopathological model paves the way to explore the contribution of 
endothelial podosome in human cardiovascular disease(s). 
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Since the last decade, a growing interest has emerged to develop autolo-
gous cell therapy with Endothelial Colony Forming Cells (ECFC) in ischemic 
disorders. However, ECFC are very rare events in adult blood, and their 
expansion in culture as well as their mobilization from bone marrow need 
to be improved. The description of vessel- derived high proliferative endothe-
lial cells resembling ECFC suggests a vascular reservoir of these cells that 
we aimed to mobilize by a local forearm ischemia. As aging is associated 
with structural and functional alteration of the endothelium, two different age 
groups of 10 volunteers were tested (20- 30y versus 60- 70y).
The vasculocompetence was evaluated by À ow- mediated dilatation and cir-
culating endothelial biomarker measurement before ischemia, just after, 2h, 
and 24h later. As culture of ECFC needs standardization, the technique was 
optimized before its application in the protocol.
To isolate ECFC from whole blood, the optimal mononuclear cells (MNC) 
seeding density was determined at 2.5x107 MNC per well. The matrix type 
(collagen, ¿ bronectin, laminin) did not inÀ uence MNC commitment to the 
endothelial lineage but ECFC cultured on laminin had a decreased in vitro and 
in vivo angiogenic potential. Fibronectin matrix was then selected for ECFC 
culture. No signi¿ cant mobilization of ECFC was observed, whatever the 
delay after ischemia, despite a correlation between the delta ECFC (2 hours 
after ischemia versus basal number) and the À ow- mediated dilatation in both 
groups. In addition, ECFC angiogenic properties were altered at 2 hours after 
the procedure.
In conclusion, using an optimized culture method, we did not observe a 
signi¿ cant ECFC mobilization upon a local ischemia procedure, independently 
of aging. The mechanisms leading to the decreased ECFC properties, probably 
related to hypoxia, are currently under investigation.
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Modulation of endothelial progenitor cells in high- fat diet mice: role of 
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Bone marrow- derived endothelial progenitor cells (EPCs) promote neo-
vascularization. Metabolic pathologies such as obesity and diabetes are asso-
ciated with decreased level circulating EPCs. Experimental studies suggest 
that stimulation of peroxisome proliferator- activated receptor (PPAR- α) 
may stimulate cell differentiation. We evaluated the effects of the PPAR- α 
pathway activation on the phenotype and the function of EPCs from mice 
fed with a high- fat diet (HFD). Male wild- type (WT) and PPAR- α- null 
(KO) mice received either a standard diet or HFD (42% Kcal from fat) 
for 12 weeks. Body weight was recorded throughout the feeding period. 
After 12 weeks, intraperitoneal glucose tolerance test was performed. Bone 
marrow- derived cells were cultured in the absence or in the presence of spe-
ci¿ c agonist PPAR- α, WY- 14643 (5 μM) for 7 days. To analyze cell phe-
notype, extensive characterization of isolated cells at day 0 and after 7 days 
of culture was performed. Labelled EPCs were analyzed by À ow cytometry 
using the anti- Sca- 1- PE/Cy7 and anti- Flk- 1- PE antibodies. We observed that 
the weight of mice and blood glucose levels are not affected by the HFD, 
however, increased epididymal adipose tissue deposition is observed only in 
WT mice. The deletion of PPAR- α increased the percentage of EPCs both at 
day 0 and after 7 days of culture. In addition, at day 0, HFD had no effect 
on the EPCs of WT mice but induced a reduction of EPCs in KO mice. 
After 7 days, HFD reduced the subpopulation of EPCs in WT mice but had 
no effect in KO mice. Finally, the agonist WY- 14643 increased the diffe-
rentiation of EPCs from WT mice fed with HFD as well as their ability to 
promote in vivo bone marrow- derived cell- mediated angiogenesis. Our study 
demonstrates that PPAR- α modulates the differentiation of bone marrow- 
derived progenitor cells. Moreover, they highlight the impaired differentia-
tion of EPCs induced by HFD that is restored, at least in part, by PPAR- α 
pathway activation.
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Autocrine production of Sonic hedgehog enhances PDGF BB- mediated 
migration of arterial Smooth Muscle Cells
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Migration is an essential step in mural cell (pericytes, vascular smooth 
muscle cells VSMC) recruitment on neovessels, and consequently for the 
maturation of these vessels. Sonic hedgehog (Shh) has been implicated in 
vessel maturation, but its action mechanisms are not de¿ ned.
We showed that the recombinant protein Shh alone did not induce cultured 
VSMC migration, although these cells expressed Shh pathway elements 
(Ptch- 1 and Smo receptors, and Gli transcription factors), and responded to 
Shh not only by activation of ERK1/2 and PI3K/Akt pathways, but also by 
Gli- mediated transcription.
However, in spite of the Shh inability to induce the SMC migration by 
itself, we found that Shh pathway potentiated the PDGF BB- induced SMC 
migration. Indeed, the inhibition of either Shh protein by a blocking antibody 
(5E1) or Hh signaling pathway by speci¿ c inhibitors of Smo (cyclopamine, 
SANT2) decreased signi¿ cantly PDGF BB- induced SMC migration. In fact, 
PDGF BB stimulation of SMC led to the expression and secretion of Shh 
(detected by qPCR, immunocytostaining and ELISA) which in turn increased 
the PDGF BB- induced SMC migration as demonstrated by the decrease of 
PDGF BB- induced migration by speci¿ c Shh siRNAs or the Shh blocking 
antibody.
In addition, we showed that the PDGF BB- mediated Shh expression was 
responsible for the speci¿ c activation of the PI3K gamma isoform, leading to 
a delayed activation of the PI3K/Akt pathway which contributed to the poten-
tiation of the PDGF BB- induced SMC migration. We also found that the Gli1 
transcriptional activity was speci¿ cally activated by autocrine Shh and that 
its blockade by either speci¿ c chemical inhibitors (GANT58, GANT61) or 
by the expression of the Gli3 repressor decreased the PDGF BB- mediated 
migration.
These results demonstrate that VSMC- produced Shh strengthens the che-
motactic activity of PDGF BB, and consequently suggest that Shh may parti-
cipate by this way to the recruitment of mural cells on neovessels.
